Caffeine, selected metabolic gene variants, and risk for neural tube defects

Rebecca Jean Schmidt, Paul A. Romitti, Trudy L. Burns, Jeffrey C. Murray, Marilyn L. Browne, Charlotte M. Druschel, Richard S. Olney

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

BACKGROUND: Investigations of maternal caffeine intake and neural tube defects (NTDs) have not considered genetic influences. Caffeine metabolism gene effects were examined in the National Birth Defects Prevention Study. METHODS: Average daily caffeine was summed from self-reported coffee, tea, soda, and chocolate intake for mothers of 768 NTD cases, and 4143 controls delivered from 1997 to 2002. A subset of 306 NTD and 669 control infants and their parents were genotyped for CYP1A2*1F, NAT2 481C>T, and NAT2 590G>A. CYP1A2*1F was classified by fast or slow oxidation status, and NAT2 variants were categorized into rapid or slow acetylation status. Case-control logistic regression analyses, family-based transmission/disequilibrium tests and log-linear analyses, and hybrid log-linear analyses were conducted to produce odds ratios (ORs) or relative risks (RRs) and 95% confidence intervals (CIs) for caffeine intake and maternal and infant gene variants, and to examine interaction effects. RESULTS: NTDs were independently associated with infant slow NAT2 acetylator status (RR, 2.00; 95% CI, 1.10-3.64) and maternal CYP1A2*1F fast oxidation status (OR, 1.49; 95% CI, 1.10-2.03). Mothers who consumed caffeine, oxidized CYP1A2*1F quickly, and acetylized NAT2 slowly had a nonsignificantly elevated estimated risk for an NTD-affected pregnancy (OR, 3.10; 95% CI, 0.86-11.21). Multiplicative interaction effects were observed between maternal caffeine and infant CYP1A2*1F fast oxidizer status (Pinteraction = 0.03). CONCLUSIONS: The association identified between maternal CYP1A2*1F fast oxidation status and NTDs should be examined further in the context of the other substrates of CYP1A2. Maternal caffeine and its metabolites may be associated with increased risk for NTD-affected pregnancies in genetically susceptible subgroups.

Original languageEnglish (US)
Pages (from-to)560-569
Number of pages10
JournalBirth Defects Research Part A - Clinical and Molecular Teratology
Volume88
Issue number7
DOIs
StatePublished - 2010

Fingerprint

Neural Tube Defects
Cytochrome P-450 CYP1A2
Caffeine
Mothers
Genes
Confidence Intervals
Odds Ratio
Pregnancy
Coffee
Tea
Acetylation
Parents
Logistic Models
Regression Analysis

Keywords

  • Adverse effects
  • Caffeine
  • Cytochrome P450 CYP1A2
  • Effect modification
  • Embryo
  • Encephalocele
  • Gene-environment interaction
  • Mammalian
  • Maternal exposure
  • Metabolism
  • N-acetyltransferase NAT2
  • Neural tube defects
  • Spinal dysraphism

ASJC Scopus subject areas

  • Developmental Biology
  • Pediatrics, Perinatology, and Child Health
  • Embryology
  • Medicine(all)

Cite this

Caffeine, selected metabolic gene variants, and risk for neural tube defects. / Schmidt, Rebecca Jean; Romitti, Paul A.; Burns, Trudy L.; Murray, Jeffrey C.; Browne, Marilyn L.; Druschel, Charlotte M.; Olney, Richard S.

In: Birth Defects Research Part A - Clinical and Molecular Teratology, Vol. 88, No. 7, 2010, p. 560-569.

Research output: Contribution to journalArticle

Schmidt, Rebecca Jean ; Romitti, Paul A. ; Burns, Trudy L. ; Murray, Jeffrey C. ; Browne, Marilyn L. ; Druschel, Charlotte M. ; Olney, Richard S. / Caffeine, selected metabolic gene variants, and risk for neural tube defects. In: Birth Defects Research Part A - Clinical and Molecular Teratology. 2010 ; Vol. 88, No. 7. pp. 560-569.
@article{516e8a3643324c0ab20f088cee6dd1df,
title = "Caffeine, selected metabolic gene variants, and risk for neural tube defects",
abstract = "BACKGROUND: Investigations of maternal caffeine intake and neural tube defects (NTDs) have not considered genetic influences. Caffeine metabolism gene effects were examined in the National Birth Defects Prevention Study. METHODS: Average daily caffeine was summed from self-reported coffee, tea, soda, and chocolate intake for mothers of 768 NTD cases, and 4143 controls delivered from 1997 to 2002. A subset of 306 NTD and 669 control infants and their parents were genotyped for CYP1A2*1F, NAT2 481C>T, and NAT2 590G>A. CYP1A2*1F was classified by fast or slow oxidation status, and NAT2 variants were categorized into rapid or slow acetylation status. Case-control logistic regression analyses, family-based transmission/disequilibrium tests and log-linear analyses, and hybrid log-linear analyses were conducted to produce odds ratios (ORs) or relative risks (RRs) and 95{\%} confidence intervals (CIs) for caffeine intake and maternal and infant gene variants, and to examine interaction effects. RESULTS: NTDs were independently associated with infant slow NAT2 acetylator status (RR, 2.00; 95{\%} CI, 1.10-3.64) and maternal CYP1A2*1F fast oxidation status (OR, 1.49; 95{\%} CI, 1.10-2.03). Mothers who consumed caffeine, oxidized CYP1A2*1F quickly, and acetylized NAT2 slowly had a nonsignificantly elevated estimated risk for an NTD-affected pregnancy (OR, 3.10; 95{\%} CI, 0.86-11.21). Multiplicative interaction effects were observed between maternal caffeine and infant CYP1A2*1F fast oxidizer status (Pinteraction = 0.03). CONCLUSIONS: The association identified between maternal CYP1A2*1F fast oxidation status and NTDs should be examined further in the context of the other substrates of CYP1A2. Maternal caffeine and its metabolites may be associated with increased risk for NTD-affected pregnancies in genetically susceptible subgroups.",
keywords = "Adverse effects, Caffeine, Cytochrome P450 CYP1A2, Effect modification, Embryo, Encephalocele, Gene-environment interaction, Mammalian, Maternal exposure, Metabolism, N-acetyltransferase NAT2, Neural tube defects, Spinal dysraphism",
author = "Schmidt, {Rebecca Jean} and Romitti, {Paul A.} and Burns, {Trudy L.} and Murray, {Jeffrey C.} and Browne, {Marilyn L.} and Druschel, {Charlotte M.} and Olney, {Richard S.}",
year = "2010",
doi = "10.1002/bdra.20681",
language = "English (US)",
volume = "88",
pages = "560--569",
journal = "Teratology",
issn = "1542-0752",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Caffeine, selected metabolic gene variants, and risk for neural tube defects

AU - Schmidt, Rebecca Jean

AU - Romitti, Paul A.

AU - Burns, Trudy L.

AU - Murray, Jeffrey C.

AU - Browne, Marilyn L.

AU - Druschel, Charlotte M.

AU - Olney, Richard S.

PY - 2010

Y1 - 2010

N2 - BACKGROUND: Investigations of maternal caffeine intake and neural tube defects (NTDs) have not considered genetic influences. Caffeine metabolism gene effects were examined in the National Birth Defects Prevention Study. METHODS: Average daily caffeine was summed from self-reported coffee, tea, soda, and chocolate intake for mothers of 768 NTD cases, and 4143 controls delivered from 1997 to 2002. A subset of 306 NTD and 669 control infants and their parents were genotyped for CYP1A2*1F, NAT2 481C>T, and NAT2 590G>A. CYP1A2*1F was classified by fast or slow oxidation status, and NAT2 variants were categorized into rapid or slow acetylation status. Case-control logistic regression analyses, family-based transmission/disequilibrium tests and log-linear analyses, and hybrid log-linear analyses were conducted to produce odds ratios (ORs) or relative risks (RRs) and 95% confidence intervals (CIs) for caffeine intake and maternal and infant gene variants, and to examine interaction effects. RESULTS: NTDs were independently associated with infant slow NAT2 acetylator status (RR, 2.00; 95% CI, 1.10-3.64) and maternal CYP1A2*1F fast oxidation status (OR, 1.49; 95% CI, 1.10-2.03). Mothers who consumed caffeine, oxidized CYP1A2*1F quickly, and acetylized NAT2 slowly had a nonsignificantly elevated estimated risk for an NTD-affected pregnancy (OR, 3.10; 95% CI, 0.86-11.21). Multiplicative interaction effects were observed between maternal caffeine and infant CYP1A2*1F fast oxidizer status (Pinteraction = 0.03). CONCLUSIONS: The association identified between maternal CYP1A2*1F fast oxidation status and NTDs should be examined further in the context of the other substrates of CYP1A2. Maternal caffeine and its metabolites may be associated with increased risk for NTD-affected pregnancies in genetically susceptible subgroups.

AB - BACKGROUND: Investigations of maternal caffeine intake and neural tube defects (NTDs) have not considered genetic influences. Caffeine metabolism gene effects were examined in the National Birth Defects Prevention Study. METHODS: Average daily caffeine was summed from self-reported coffee, tea, soda, and chocolate intake for mothers of 768 NTD cases, and 4143 controls delivered from 1997 to 2002. A subset of 306 NTD and 669 control infants and their parents were genotyped for CYP1A2*1F, NAT2 481C>T, and NAT2 590G>A. CYP1A2*1F was classified by fast or slow oxidation status, and NAT2 variants were categorized into rapid or slow acetylation status. Case-control logistic regression analyses, family-based transmission/disequilibrium tests and log-linear analyses, and hybrid log-linear analyses were conducted to produce odds ratios (ORs) or relative risks (RRs) and 95% confidence intervals (CIs) for caffeine intake and maternal and infant gene variants, and to examine interaction effects. RESULTS: NTDs were independently associated with infant slow NAT2 acetylator status (RR, 2.00; 95% CI, 1.10-3.64) and maternal CYP1A2*1F fast oxidation status (OR, 1.49; 95% CI, 1.10-2.03). Mothers who consumed caffeine, oxidized CYP1A2*1F quickly, and acetylized NAT2 slowly had a nonsignificantly elevated estimated risk for an NTD-affected pregnancy (OR, 3.10; 95% CI, 0.86-11.21). Multiplicative interaction effects were observed between maternal caffeine and infant CYP1A2*1F fast oxidizer status (Pinteraction = 0.03). CONCLUSIONS: The association identified between maternal CYP1A2*1F fast oxidation status and NTDs should be examined further in the context of the other substrates of CYP1A2. Maternal caffeine and its metabolites may be associated with increased risk for NTD-affected pregnancies in genetically susceptible subgroups.

KW - Adverse effects

KW - Caffeine

KW - Cytochrome P450 CYP1A2

KW - Effect modification

KW - Embryo

KW - Encephalocele

KW - Gene-environment interaction

KW - Mammalian

KW - Maternal exposure

KW - Metabolism

KW - N-acetyltransferase NAT2

KW - Neural tube defects

KW - Spinal dysraphism

UR - http://www.scopus.com/inward/record.url?scp=77954703370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954703370&partnerID=8YFLogxK

U2 - 10.1002/bdra.20681

DO - 10.1002/bdra.20681

M3 - Article

C2 - 20641098

AN - SCOPUS:77954703370

VL - 88

SP - 560

EP - 569

JO - Teratology

JF - Teratology

SN - 1542-0752

IS - 7

ER -